Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Houston American Energy Corp HUSA

Houston American Energy Corp. is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its principal properties, and operations, are in the United States Permian Basin and the South American country of Colombia. Additionally, it has properties in the Louisiana United States Gulf Coast region. Its Texas properties include Reeves County and Yoakum County. It holds an 18.1% average working interest in 320 gross acres in Reeves County, Texas, consisting of over 160 gross acres Johnson Lease and 160 gross acres O’Brien Lease, in which the Company holds an average 11.2% working interest. Its property in Louisiana consists of a 23.4% mineral interest in 2,485 gross acres in East Baton Rouge Parish. It has interests in a single block, through Hupecol Meta, LLC, operated by Hupecol Operating and affiliates, in Colombia, covering approximately 639,405 gross acres.


NYSEAM:HUSA - Post by User

Post by GwenTracyon Apr 19, 2022 11:18pm
130 Views
Post# 34615371

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS Video


FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!

<< Previous
Bullboard Posts
Next >>